Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Brantley KD, Rosenberg SM, Collins LC, Ruddy KJ, Tamimi RM, Schapira L, et al. Second Primary Breast Cancer in Young Breast Cancer Survivors. JAMA Oncol. 2024;10(6):718-725.

Magro C, Tili E, Nuovo G. Disruption of the blood-brain barrier is correlated with spike endocytosis by ACE2 + endothelia in the CNS microvasculature in fatal COVID-19. . Acta Neuropathol. 2024;147(1):47.

Sumiyoshi T, Wang X, Warner EW, Sboner A, Annala M, Sigouros M, et al. Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial. J Natl Cancer Inst. 2024;116(1):115-126.

Xu X, Feng J, Wang X, Zeng X, Luo Y, He X, et al. Mitochondrial GRIM19 Loss Induces Liver Fibrosis through NLRP3/IL33 Activation via Reactive Oxygen Species/NF-кB Signaling. J Clin Transl Hepatol. 2024;12(6):539-550.

Mueller FB, Yang H, Li C, Dadhania DM, Xiang JZ, Salvatore SP, et al. RNA-sequencing of Human Kidney Allografts and Delineation of T-Cell Genes, Gene Sets, and Pathways Associated With Acute T Cell-mediated Rejection. Transplantation. 2024;108(4):911-922.

Nooruzzaman M, Johnson KE, Rani R, Finkelsztein EJ, Caserta LC, Kodiyanplakkal RP, et al. Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections. medRxiv. 2024.

Bergom HE, Sena LA, Day A, Miller B, Miller CD, Lozada JR, et al. Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer. NPJ Genom Med. 2024;9(1):7.

Wheeler AP, Snyder EL, Refaai MA, Cohn CS, Poisson J, Fontaine MJ, et al. Acute Pulmonary Injury in Hematology Patients Supported with Pathogen Reduced and Conventional Platelet Components. Blood Adv. 2024.

Izadmehr S, Fernandez-Hernandez H, Wiredja D, Kirschenbaum A, Lee-Poturalski C, Tavassoli P, et al. Cooperativity of c-MYC with Krüppel-Like Factor 6 Splice Variant 1 induces phenotypic plasticity and promotes prostate cancer progression and metastasis. bioRxiv. 2024.

Hsu H, Zanettini C, Coker M, Boudova S, Rach D, Mvula G, et al. Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential. Cell Immunol. 2024;395-396:104797.